Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-25

Clinical Trial Update: Investigating Patient Satisfaction With Oral Anti-Cancer Treatment

View source ↗

Summary

A completed clinical trial investigating patient satisfaction with an oral anti-cancer treatment sponsored by KU Leuven for Clear Cell Renal Cell Carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: KU Leuven | Conditions: Clear Cell Renal Cell Carcinoma | Status: COMPLETED